Pranav M. Patel

Pranav M. Patel

Auto-generated profile, based on publicly available information

Pranav M. Patel

Division of Cardiology, Department of Medicine, University of California Irvine Medical Center, Orange, California, CA, United States

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2024 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
MAMark W. Abdelnour
Mark W. Abdelnour
VPVishal Patel
Vishal Patel
PPPranav M. Patel
Pranav M. Patel
AKA. M. Kasel
A. M. Kasel
AFAntonio H Frangieh
Antonio H Frangieh
Aortic Stenosis (AS) is a common condition with an estimated pooled prevalence of all AS in the elderly population at around 12.4%, with that of severe AS estimated to be around 3.4%. In the past, surgical aortic valve replacement was the primary treatment option for severe AS for decades. However, with the compelling evidence on the safety and efficacy of transcatheter aortic valve replacement (TAVR), it has become the gold standard treatment option for many patients with symptomatic severe AS. Transfemoral access has been the preferred method for transcatheter heart valve delivery. However, the prevalent use of TAVR on a diverse patient profile with different risk factors, such as peripheral artery disease, precluded the possibility of a transfemoral approach despite the improvement of valves and delivery systems technology. Therefore, alternative TAVR approaches have gained increasing utility in cases where transfemoral access is unfavorable. We review the journey, evolution, and techniques for different approaches of percutaneous TAVR, including transfemoral, transcarotid, transsubclavian/transaxillary, and transcaval approaches, in addition to the traditional “surgical” transaortic and transapical accesses. Consolidating these data highlights each approach's practicality and limitations, providing additional grounding for case-by-case utilization and future clinical research.

22 August 2023 in The FASEB Journal
Verified
Journal Article
Closed access
JSJonathan Schilling
Jonathan Schilling
JLJeannette P. Lin
Jeannette P. Lin
SMSunil V. Mankad
Sunil V. Mankad
MKMayil S. Krishnam
Mayil S. Krishnam
MNMingMing Ning
MingMing Ning
MFMark J. Fisher
Mark J. Fisher

28 January 2021 in BMJ Case Reports
Verified
Journal Article
Open access
PDF file
VTVittorio Romeo Terrigno
Vittorio Romeo Terrigno
DRDaniel Anthony Ricketti
Daniel Anthony Ricketti
PPPranav Patel
Pranav Patel
SRSatyajeet Roy
Satyajeet Roy
We present a case of a 38-year-old man with a history of chronic thromboembolic pulmonary hypertension on therapeutic anticoagulation and recent hospitalisation for COVID-19 disease who was hospitalised for recurrent acute pulmonary embolism despite therapeutic anticoagulation with warfarin (International Normalized Ratio (INR) of 3.0). Our case highlights the hypercoagulable state associated with COVID-19 disease and the absence of standardised approaches to anticoagulation treatment for this population.